Top Institutions in Ophthalmology
Leading academic ophthalmology centers and research institutions with strong retinal disease programs and extensive clinical trial and real-world data registries contribute significantly to research on anti-VEGF therapies like Eylea HD. These institutions often lead multicenter studies, maintain large patient registries, and have expertise in retinal imaging and outcomes analysis.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a leading retina service that conducts extensive clinical trials and real-world studies on retinal diseases including nAMD and DME. They have strong expertise in anti-VEGF therapies and advanced retinal imaging.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is renowned for its research in retinal diseases and development of novel therapies. It has a robust clinical trials infrastructure and collaborates on large registries like IRIS, contributing to real-world data analyses.
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a long-standing reputation for excellence in retinal disease management and research. It frequently leads clinical trials on anti-VEGF agents and contributes to real-world evidence generation through large patient databases.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a top-tier ophthalmology center with a strong focus on retinal diseases and innovative therapies. It has significant involvement in clinical trials and real-world data research for anti-VEGF treatments.